ArticleJAMA2023

Discontinuation of Conventional Synthetic Disease-Modifying Antirheumatic Drugs in Patients With Rheumatoid Arthritis and Excellent Disease Control.

Siri Lillegraven et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.